MedPath

Paion UK Ltd.

🇬🇧United Kingdom
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.paion.com

Clinical Trials

14

Active:0
Completed:13

Trial Phases

3 Phases

Phase 1:5
Phase 2:3
Phase 3:6

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (14 trials with phase data)• Click on a phase to view related trials

Phase 3
6 (42.9%)
Phase 1
5 (35.7%)
Phase 2
3 (21.4%)

Assessment of the Pharmacodynamic and Pharmacokinetic Interaction of Remimazolam and Remifentanil

Phase 1
Completed
Conditions
Anesthesia
Interventions
First Posted Date
2020-12-17
Last Posted Date
2023-09-11
Lead Sponsor
Paion UK Ltd.
Target Recruit Count
28
Registration Number
NCT04670471
Locations
🇳🇱

University Medical Center Groningen, Groningen, Netherlands

Absolute Oral Bioavailability of Remimazolam

Phase 1
Completed
Conditions
Bioavailability
Interventions
First Posted Date
2019-10-02
Last Posted Date
2019-10-02
Lead Sponsor
Paion UK Ltd.
Target Recruit Count
14
Registration Number
NCT04113564
Locations
🇺🇸

PRA Health Sciences (PRA) - Early Development Services (EDS), Salt Lake City, Utah, United States

Oral Remimazolam With and Without Alcohol in Healthy Female Subjects

Phase 1
Completed
Conditions
Safety Issues
Interventions
Other: Alcohol
First Posted Date
2019-10-02
Last Posted Date
2019-10-02
Lead Sponsor
Paion UK Ltd.
Target Recruit Count
21
Registration Number
NCT04113343
Locations
🇺🇸

PRA Health Sciences (PRA) - Early Development Services, Salt Lake City, Utah, United States

Abuse Potential of Intravenous Remimazolam Compared to Midazolam and Placebo in Recreational CNS Depressant Users

Phase 1
Completed
Conditions
Abuse, Drug
Interventions
First Posted Date
2019-10-01
Last Posted Date
2019-10-01
Lead Sponsor
Paion UK Ltd.
Target Recruit Count
83
Registration Number
NCT04110535
Locations
🇺🇸

PRA Health Sciences Early Development Services, Salt Lake City, Utah, United States

Efficacy and Safety of Remimazolam (CNS7056) Compared to Propofol for Intravenous Anesthesia During Elective Surgery

Phase 3
Completed
Conditions
Anesthesia, Intravenous
Interventions
First Posted Date
2018-09-07
Last Posted Date
2020-05-28
Lead Sponsor
Paion UK Ltd.
Target Recruit Count
469
Registration Number
NCT03661489
Locations
🇩🇪

University of Erlangen, Erlangen, Bavaria, Germany

  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.